Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-049765
Date:2021-08-03
Issuer: TENAYA THERAPEUTICS, INC. (TNYA)
Original Submission Date:

Reporting Person:

CASDIN PARTNERS MASTER FUND, L.P.
1350 AVENUE OF THE AMERICAS
SUITE 2600 NEW YORK, NY 10019

Reporting Person:

CASDIN PRIVATE GROWTH EQUITY FUND, L.P.
1350 AVENUE OF THE AMERICAS
SUITE 2600 NEW YORK, NY 94080

Reporting Person:

CASDIN CAPITAL, LLC
1350 AVENUE OF THE AMERICAS
SUITE 2600 NEW YORK, NY 10019

Reporting Person:

CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC
1350 AVENUE OF THE AMERICAS
SUITE 2600 NEW YORK, NY 10019

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-08-03 C 2,374,849 a $0.00 2,374,849 indirect
COMMON STOCK 2021-08-03 P 850,000 a $15.00 3,224,849 indirect
COMMON STOCK 2021-08-03 C 361,969 a $0.00 361,969 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
SERIES B PREFERRED STOCK 0.0 2021-08-03 deemed execution date C 2,012,880 (d) common stock 2,012,880 $0.00 0 indirect see footnotes
SERIES C PREFERRED STOCK 0.0 2021-08-03 deemed execution date C 361,969 (d) common stock 361,969 $0.00 0 indirect see footnotes
SERIES C PREFERRED STOCK 0.0 2021-08-03 deemed execution date C 361,969 (d) common stock 361,969 $0.00 0 indirect see footnotes
Footnotes
IDfootnote
f1 these shares are held directly by casdin partners master fund, l.p.(cpmf).
f2 casdin capital, llc is the investment advisor to cpmf and cpgef. casdin partners gp, llc is the general partner of cpmf. casdin private growth equity fund gp, llc is the general partner of cpgef. the reporting person is the managing member of casdin capital, llc, casdin partners gp, llc and casdin private growth equity fund gp, llc and may be deemed to have voting and investment power with respect to the shares. the reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
f3 these shares are held directly by casdin private growth equity fund, l.p. (cpgef).
f4 each share of series a preferred stock, series b preferred stock and series c preferred stock automatically converted into one share of common stock immediately prior to the completion of the issuer's initial public offering, and had no expiration date.
WhaleWisdom Logo

Elevate your investments